Bank Of New York Mellon Corp Kala Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.31 $40,125 - $175,216	-133,753 Reduced 87.53%	19,050 $6,000
Q1 2022 May 11, 2022	SELL	$0.61 - $1.84 $1,196 - $3,608	-1,961 Reduced 1.27%	152,803 $211,000
Q4 2021 Feb 11, 2022	SELL	$1.16 - $2.74 $39,633 - $93,617	-34,167 Reduced 18.08%	154,764 $188,000
Q3 2021 Nov 12, 2021	BUY	$2.62 - $5.43 $25,262 - $52,356	9,642 Added 5.38%	188,931 $495,000
Q2 2021 Aug 11, 2021	BUY	$5.06 - $8.15 $42,013 - $67,669	8,303 Added 4.86%	179,289 $950,000
Q1 2021 May 13, 2021	SELL	$6.24 - $9.58 $23,144 - $35,532	-3,709 Reduced 2.12%	170,986 $1.15 Million
Q4 2020 Feb 09, 2021	SELL	$6.28 - $8.79 $60,470 - $84,638	-9,629 Reduced 5.22%	174,695 $1.18 Million
Q3 2020 Nov 12, 2020	SELL	$7.5 - $11.11 $326,857 - $484,184	-43,581 Reduced 19.12%	184,324 $1.38 Million
Q2 2020 Aug 12, 2020	BUY	$8.33 - $13.79 $583,141 - $965,368	70,005 Added 44.34%	227,905 $2.4 Million
Q1 2020 May 06, 2020	BUY	$3.83 - $8.79 $273,963 - $628,757	71,531 Added 82.82%	157,900 $1.39 Million
Q4 2019 Feb 14, 2020	SELL	$3.36 - $4.81 $37,537 - $53,737	-11,172 Reduced 11.45%	86,369 $318,000
Q3 2019 Nov 07, 2019	BUY	$3.57 - $6.58 $65,259 - $120,282	18,280 Added 23.06%	97,541 $371,000
Q2 2019 Aug 12, 2019	BUY	$4.93 - $8.8 $101,558 - $181,280	20,600 Added 35.12%	79,261 $506,000
Q1 2019 May 14, 2019	BUY	$5.19 - $8.97 $3,892 - $6,727	750 Added 1.3%	58,661 $485,000
Q4 2018 Feb 11, 2019	BUY	$4.29 - $9.94 $79,210 - $183,532	18,464 Added 46.81%	57,911 $283,000
Q3 2018 Nov 09, 2018	SELL	$9.54 - $13.87 $17,935 - $26,075	-1,880 Reduced 4.55%	39,447 $0
Q2 2018 Aug 06, 2018	BUY	$13.3 - $17.49 $103,527 - $136,142	7,784 Added 23.21%	41,327 $568,000
Q1 2018 May 15, 2018	BUY	$12.26 - $18.98 $139,960 - $216,675	11,416 Added 51.59%	33,543 $531,000
Q4 2017 Feb 09, 2018	BUY	$13.68 - $23.17 $302,697 - $512,682	22,127	22,127 $409,000

Others Institutions Holding KALA

# of Institutions

Shares Held

Call Options Held

Put Options Held

Parallel Advisors, LLC

1
Shares

$5
0.0% of portfolio

View Full List

About Kala Pharmaceuticals, Inc.

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

More about KALA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account